Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Woosley

Showing results (181-190 of 201) with videos related to

Pageof 21
Sort By:
Clinical Pharmacology and Therapeutics|May 1, 1989
Mexiletine and tocainide: a comparison of antiarrhythmic efficacy, adverse effects, and predictive value of lidocaine testingK T Murray, J T Barbey, H A Kopelman, et al.
Journal of the American College of Cardiology|January 1, 1996
Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias. Intravenous Amiodarone Multicenter Trial GroupJ H Levine, A Massumi, M M Scheinman, et al.
Clinical Pharmacology and Therapeutics|May 1, 1988
The development and testing of intravenous dosing regimens: application to flecainide for the suppression of ventricular arrhythmiasT Wang, L A Siddoway, K A Thompson, et al.
American Heart Journal|March 1, 1984
Molecular basis for the antigenicity of lidocaine analogs: tocainide and mexiletineH J Duff, D M Roden, S Marney, et al.
Journal of the American College of Cardiology|April 1, 1994
New insights into the definition and meaning of proarrhythmia during initiation of antiarrhythmic drug therapy from the Cardiac Arrhythmia Suppression Trial and its pilot study. The CAST and CAPS InvestigatorsD G Wyse, J Morganroth, R Ledingham, et al.
Pharmacogenetics|December 1, 1993
Relationship of CYP2D6 (debrisoquine hydroxylase) genotype to breast cancer susceptibilityE T Buchert, R L Woosley, S M Swain, et al.
The American Journal of Cardiology|April 30, 1987
Proarrhythmia, arrhythmogenesis or aggravation of arrhythmia--a status report, 1987L N Horowitz, D P Zipes, J T Bigger, et al.
Carcinogenesis|April 1, 1993
N-acetylation phenotype and genotype and risk of bladder cancer in benzidine-exposed workersR B Hayes, W Bi, N Rothman, et al.
Pharmacogenetics|October 1, 1993
Correlation between N-acetyltransferase activity and NAT2 genotype in Chinese malesN Rothman, R B Hayes, W Bi, et al.
The Journal of Clinical Investigation|February 1, 1984
Encainide and its metabolites. Comparative effects in man on ventricular arrhythmia and electrocardiographic intervalsE L Carey, H J Duff, D M Roden, et al.
Pageof 21

Showing results (181-190 of 201) with videos related to

Sort By:
Pageof 21
Clinical Pharmacology and Therapeutics|May 1, 1989
Mexiletine and tocainide: a comparison of antiarrhythmic efficacy, adverse effects, and predictive value of lidocaine testingK T Murray, J T Barbey, H A Kopelman, et al.
Journal of the American College of Cardiology|January 1, 1996
Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias. Intravenous Amiodarone Multicenter Trial GroupJ H Levine, A Massumi, M M Scheinman, et al.
Clinical Pharmacology and Therapeutics|May 1, 1988
The development and testing of intravenous dosing regimens: application to flecainide for the suppression of ventricular arrhythmiasT Wang, L A Siddoway, K A Thompson, et al.
American Heart Journal|March 1, 1984
Molecular basis for the antigenicity of lidocaine analogs: tocainide and mexiletineH J Duff, D M Roden, S Marney, et al.
Journal of the American College of Cardiology|April 1, 1994
New insights into the definition and meaning of proarrhythmia during initiation of antiarrhythmic drug therapy from the Cardiac Arrhythmia Suppression Trial and its pilot study. The CAST and CAPS InvestigatorsD G Wyse, J Morganroth, R Ledingham, et al.
Pharmacogenetics|December 1, 1993
Relationship of CYP2D6 (debrisoquine hydroxylase) genotype to breast cancer susceptibilityE T Buchert, R L Woosley, S M Swain, et al.
The American Journal of Cardiology|April 30, 1987
Proarrhythmia, arrhythmogenesis or aggravation of arrhythmia--a status report, 1987L N Horowitz, D P Zipes, J T Bigger, et al.
Carcinogenesis|April 1, 1993
N-acetylation phenotype and genotype and risk of bladder cancer in benzidine-exposed workersR B Hayes, W Bi, N Rothman, et al.
Pharmacogenetics|October 1, 1993
Correlation between N-acetyltransferase activity and NAT2 genotype in Chinese malesN Rothman, R B Hayes, W Bi, et al.
The Journal of Clinical Investigation|February 1, 1984
Encainide and its metabolites. Comparative effects in man on ventricular arrhythmia and electrocardiographic intervalsE L Carey, H J Duff, D M Roden, et al.
Pageof 21